Dr. Bronstein, the DeepMind Professor of AI at Oxford, will help VantAI unlock the potential of induced proximityNEW YORK, July...
New service leverages speech recognition and generative AI to automatically create preliminary clinical documentation from patient-clinician conversations 3M Health Information...
Constant Therapy Health grants researchers at Boston University and The University of Texas at Austin access to world’s largest speech...
BOSTON, July 26, 2023 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a clinical stage biotechnology company developing novel...
Beverly Hills, California, July 24, 2023 (GLOBE NEWSWIRE) -- MDbio – The Doctors BrandTM published a new article about artificial intelligence...
Press release Molecure completes successful Secondary Public Offering (SPO) of approximately PLN 50 million (USD 12 million) with proceeds to...
AI Start-up Pioneering Generative AI for Healthcare Receives $13M in Early Funding, Adds Industry Luminaries as Advisors, and Kicks off...
Surrounded by world renowned universities and medical centers,Predictive Oncology is part of the next generation of Pittsburgh’s innovation ecosystem PITTSBURGH,...
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, is pleased to announce it has acquired Comsort, Inc....
Company to educate and guide best practices for maintaining resiliency in the face of increasing ransomware attacks in healthcarePLEASANTON, Calif.,...
Innovative Tech Utilizes AI/ML, IoT/BLE Devices, and Digital WhiteboardsATLANTA, GA / ACCESSWIRE / July 11, 2023 / Vizzia Technologies, a...
Innovative Tech Utilizes AI/ML, IoT/BLE Devices, and Digital WhiteboardsATLANTA, GA / ACCESSWIRE / July 11, 2023 / Vizzia Technologies, a...
CAMBRIDGE, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science...
SAN FRANCISCO, July 11, 2023 (GLOBE NEWSWIRE) -- Artificial intelligence and machine learning innovator McClintock LLC has entered into a...
Vital breakthrough for Alzheimer's patients worldwide with Eisai's Leqembi FDA approval; Cognetivity Neurosciences' AI CognICA technology poised to play pivotal...
Breakthrough in diagnostics testing enables ‘facial recognition for germs’ Collaboration with John Radcliffe Hospital used AI to identify respiratory viruses...
BOSTON, July 10, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on developing novel...
NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) -- Advanced Health Intelligence Ltd (ASX/NASDAQ:AHI) (“Advanced Health Intelligence”, “AHI” or the “Company”)...
Trial met primary endpoint with the 60 mcg dose, with BXCL501 demonstrating a statistically significant 39% greater reduction in PEC...
Vaccines Investor EventVaccines R&D pipeline raises the bar in RSV, influenza, meningitis, and pneumococcal disease Sanofi reaffirms ambition to...